Jens Sandahl Christiansen
#126,393
Most Influential Person Now
Jens Sandahl Christiansen's AcademicInfluence.com Rankings
Jens Sandahl Christiansenphilosophy Degrees
Philosophy
#5941
World Rank
#8879
Historical Rank
Ontology
#47
World Rank
#56
Historical Rank
Logic
#3144
World Rank
#4261
Historical Rank
Jens Sandahl Christiansenbiology Degrees
Biology
#8027
World Rank
#11038
Historical Rank
Endocrinology
#84
World Rank
#95
Historical Rank
Download Badge
Philosophy Biology
Jens Sandahl Christiansen's Degrees
- PhD Endocrinology University of Copenhagen
- Doctorate Medicine University of Copenhagen
Why Is Jens Sandahl Christiansen Influential?
(Suggest an Edit or Addition)Jens Sandahl Christiansen's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS (1989) (894)
- Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review (1998) (800)
- Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. (1998) (675)
- Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. (1982) (613)
- Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria (1994) (576)
- Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study (1983) (549)
- Weight loss increases circulating levels of ghrelin in human obesity (2002) (528)
- Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. (2003) (483)
- Hemodynamic factors in the genesis of diabetic microangiopathy. (1983) (344)
- Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models. (2008) (274)
- Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. (1998) (262)
- Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. (1989) (259)
- Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome (2013) (256)
- Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport. (1999) (255)
- Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. (2000) (248)
- Clinical and epidemiological description of aortic dissection in Turner's syndrome (2006) (242)
- Kidney function and size in diabetics before and during initial insulin treatment. (1982) (203)
- Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. (2011) (201)
- Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. (1990) (199)
- Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans. (2002) (198)
- Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance. (1994) (192)
- Glucose Metabolism, Lipid Metabolism, and Cardiovascular Risk Factors in Adult Turner's Syndrome: The impact of sex hormone replacement (1998) (192)
- GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults (2015) (178)
- A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum. (2003) (175)
- Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society. (2001) (171)
- Plasma ghrelin levels during exercise in healthy subjects and in growth hormone-deficient patients. (2002) (157)
- Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men. (2013) (156)
- Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria (1996) (151)
- Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose‐dependent manner and suppresses circadian thyrotrophin levels: studies in GH‐deficient adults (1994) (147)
- Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults. (1996) (145)
- Long-term growth hormone treatment in growth hormone deficient adults. (1991) (140)
- Cigarette Smoking and Prevalence of Microangiopathy in Juvenile-Onset Insulin-dependent Diabetes Mellitus (1978) (140)
- Ghrelin immunoreactivity in human plasma is suppressed by somatostatin (2002) (140)
- Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics (1981) (140)
- Kidney function and size in normal subjects before and during growth hormone administration for one week (1981) (138)
- Effects of cortisol on carbohydrate, lipid, and protein metabolism: studies of acute cortisol withdrawal in adrenocortical failure. (2007) (137)
- Detection of growth hormone abuse in sport. (2007) (132)
- Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. (1996) (129)
- Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. (2001) (123)
- Effects of a physiological GH pulse on interstitial glycerol in abdominal and femoral adipose tissue. (1999) (123)
- Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey (2003) (121)
- Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study. (2000) (121)
- The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone. (1994) (120)
- Insulin increases glucose transfer across the blood-brain barrier in man. (1981) (119)
- Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man. (1991) (118)
- The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group. (2000) (117)
- Diabetic Nephropathy and Arterial Hypertension: The Effect of Antihypertensive Treatment (1983) (117)
- Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women. (1998) (114)
- Elevated levels of mannan-binding lectin in patients with type 1 diabetes. (2003) (110)
- The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. (2003) (109)
- Effects of indomethacin on glomerular hemodynamics in experimental diabetes. (1986) (108)
- The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults. (2000) (108)
- Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult turner syndrome: a cross-sectional study. (2002) (108)
- Short and long‐term cardiovascular effects of growth hormone therapy in growth hormone deficient adults (1994) (103)
- Constant intravenous ghrelin infusion in healthy young men: clinical pharmacokinetics and metabolic effects. (2007) (103)
- Growth hormone replacement therapy for adults: into the new millennium. (2002) (102)
- Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients. (1991) (101)
- Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. (2009) (98)
- Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations (2016) (98)
- Short‐term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial (2016) (97)
- Growth Hormone and Glucose Homeostasis (2004) (97)
- Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices. (1990) (96)
- Ambulatory blood pressure in microalbuminuric type 1 diabetic patients. (1992) (96)
- Effects of growth hormone on glucose metabolism. (1991) (96)
- Premixed insulin treatment for type 2 diabetes: analogue or human? (2007) (93)
- Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics. (2007) (91)
- Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults. (1990) (91)
- Comparison of Insulin Degludec/Insulin Aspart and Biphasic Insulin Aspart 30 in Uncontrolled, Insulin-Treated Type 2 Diabetes: A Phase 3a, Randomized, Treat-to-Target Trial (2014) (91)
- Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes (2014) (91)
- Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. (2006) (91)
- Renal function in streptozotocin-diabetic rats (1981) (89)
- Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year. (1997) (89)
- Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial. (2014) (88)
- Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients. (2000) (87)
- Thoracic aortopathy in Turner syndrome and the influence of bicuspid aortic valves and blood pressure: a CMR study (2010) (86)
- Rapid changes in chromatographically determined haemoglobin A1c induced by short-term changes in glucose concentration (1980) (86)
- Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome (2006) (86)
- The ghrelin response to exercise before and after growth hormone administration. (2007) (85)
- Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism: studies in GH-deficient patients and healthy untreated subjects. (1993) (85)
- Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary function (2007) (84)
- Reduction of Glomerular Hyperfiltration in Normoalbuminuric IDDM Patients by 6 mo of Aldose Reductase Inhibition (1991) (84)
- Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults. (2001) (84)
- Dilation of the ascending aorta in Turner syndrome - a prospective cardiovascular magnetic resonance study (2011) (83)
- Incidence of GH deficiency - a nationwide study. (2006) (81)
- Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes (2003) (80)
- Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure (2006) (79)
- Decreased plasma and extracellular volume in growth hormone deficient adults and the acute and prolonged effects of GH administration: a controlled experimental study. (1996) (78)
- Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients. (1995) (77)
- Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition. (1997) (77)
- The Effects of MK‐0677, an Oral Growth Hormone Secretagogue, in Patients with Hip Fracture (2004) (75)
- Frequent occurrence of pituitary apoplexy in patients with non‐functioning pituitary adenoma (2006) (74)
- Effects of growth hormone administration on fuel oxidation and thyroid function in normal man. (1992) (73)
- Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters (1993) (72)
- Effects of growth hormone on glucose and fat metabolism in human subjects. (2007) (70)
- Autonomic and Somatosensory Nerve Function After 2 Years of Continuous Subcutaneous Insulin Infusion in Type I Diabetes (1988) (70)
- Mortality and GH deficiency: a nationwide study. (2007) (70)
- Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism. (2000) (69)
- Fuel metabolism, energy expenditure, and thyroid function in growth hormone-treated obese women: a double-blind placebo-controlled study. (1994) (69)
- Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis. (2009) (69)
- Abnormalities of the major intrathoracic arteries in Turner syndrome as revealed by magnetic resonance imaging (2010) (66)
- Body Composition and Physical Fitness Are Major Determinants of the Growth Hormone-Insulin-Like Growth Factor Axis Aberrations in Adult Turner’s Syndrome, with Important Modulations by Treatment with 17β-Estradiol1 (1997) (65)
- Beneficial effects of GH replacement therapy in adults. (1991) (65)
- Diabetes as a case study of chronic disease management with a personalized approach: the role of a structured feedback loop. (2012) (65)
- The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown. (2001) (64)
- Morbidity and GH deficiency: a nationwide study. (2007) (64)
- Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome. (2010) (63)
- Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onset. (1994) (63)
- The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone. (2003) (63)
- Prevalence of posttraumatic growth hormone deficiency is highly dependent on the diagnostic set-up: results from The Danish National Study on Posttraumatic Hypopituitarism. (2012) (62)
- Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial. (2015) (62)
- One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study. (2010) (60)
- Status of long-acting-growth hormone preparations--2015. (2015) (60)
- Prevalence of diabetic autonomic neuropathy measured by simple bedside tests (1981) (60)
- Impaired autoregulation of glomerular filtration rate in Type 1 (insulin-dependent) diabetic patients with nephropathy (1984) (60)
- Determinants of serum insulin‐like growth factor I in growth hormone deficient adults as compared to healthy subjects (1998) (59)
- Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue. (2006) (59)
- Effect of intravenous glucose infusion on renal function in normal man and in insulin-dependent diabetics (1981) (57)
- Circadian patterns of serum insulin-like growth factor (IGF) II and IGF binding protein 3 in growth hormone-deficient patients and age- and sex-matched normal subjects. (1990) (57)
- The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy (2014) (57)
- Effects of exercise on VLDL-triglyceride oxidation and turnover. (2011) (57)
- Abdominal fat determines growth hormone-binding protein levels in healthy nonobese adults. (1997) (56)
- Blockade of the renin-angiotensin-aldosterone system prevents growth hormone-induced fluid retention in humans. (1997) (56)
- GH strongly affects serum concentrations of mannan-binding lectin: evidence for a new IGF-I independent immunomodulatory effect of GH. (2001) (56)
- Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males (2014) (55)
- Strict metabolic control and renal function in the streptozotocin diabetic rat. (1987) (55)
- Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study. (2002) (55)
- Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study. (2000) (55)
- Normal Physiology of Growth Hormone in Adults (2015) (54)
- Effects of growth hormone on renal tubular handling of sodium in healthy humans. (2001) (53)
- Metabolic effects of growth hormone in humans. (1995) (53)
- No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes. (2001) (53)
- Insulin analogues and severe hypoglycaemia in type 1 diabetes. (2012) (52)
- Dose dependency of the pharmacokinetics and acute lipolytic actions of growth hormone. (2002) (52)
- Effects of Growth Hormone Replacement Therapy on IGF-Related Parameters and on the Pituitary-Gonadal Axis in GH-Deficient Males (1998) (52)
- Night blood pressure and cigarette smoking: disparate association in healthy subjects and diabetic patients. (1994) (51)
- Growth hormone replacement throughout life: insights into age-related responses to treatment. (2007) (51)
- Cardiac Hyperfunction in Insulin-Dependent Diabetic Patients Developing Microvascular Complications (1988) (51)
- Continuous glucose monitoring in interstitial subcutaneous adipose tissue and skeletal muscle reflects excursions in cerebral cortex. (2005) (51)
- Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency. Growth Hormone Research Society. (1998) (51)
- Growth hormone deficiency and hyperthermia during exercise: a controlled study of sixteen GH-deficient patients. (1995) (50)
- Basal and Insulin Mediated VLDL-Triglyceride Kinetics in Type 2 Diabetic Men (2010) (50)
- The aging population--is there a role for endocrine interventions? (2009) (49)
- Prognosis for juvenile diabetics with nephropathy and failing renal function. (2009) (48)
- Effects of growth hormone in patients with tibial fracture: a randomised, double-blind, placebo-controlled clinical trial. (2007) (48)
- Calorigenic effects of growth hormone: the role of thyroid hormones. (1996) (48)
- Skin morphological changes in growth hormone deficiency and acromegaly. (2001) (48)
- Carotid-Femoral Pulse Wave Velocity Is Associated With Cerebral White Matter Lesions in Type 2 Diabetes (2013) (48)
- The diagnosis of growth hormone deficiency (GHD) in adults. (1995) (47)
- Impact of GHBP interference on estimates of GH and GH pharmacokinetics (2002) (47)
- Tissue Renin–Angiotensin Systems: A Unifying Hypothesis of Metabolic Disease (2014) (47)
- Preferential stimulation of abdominal subcutaneous lipolysis after prednisolone exposure in humans. (2002) (47)
- Effects of leptin on basal and FSH stimulated steroidogenesis in human granulosa luteal cells (2000) (46)
- Normoalbuminuria ensures no reduction of renal function in type 1 (insulin‐dependent) diabetic patients (1992) (46)
- Thyroid function during growth hormone therapy. (1992) (46)
- Free fatty acids decrease circulating ghrelin concentrations in humans. (2006) (45)
- Quantitative liver functions in Turner syndrome with and without hormone replacement therapy. (2007) (45)
- Resting metabolic rate in healthy adults: Relation to growth hormone status and leptin levels (1998) (45)
- Bioavailability and bioactivity of three different doses of nasal growth hormone (GH) administered to GH-deficient patients: comparison with intravenous and subcutaneous administration. (1996) (45)
- Acute Effects of a Somatostatin Analogue on Kidney Function in Type 1 Diabetic Patients (1990) (45)
- Evidence supporting a direct suppressive effect of growth hormone on serum IGFBP-1 levels. Experimental studies in normal, obese and GH-deficient adults. (1999) (44)
- Circadian variation of blood pressure in patients with diabetic nephropathy (1992) (44)
- Serum levels of bioactive IGF1 and physiological markers of ageing in healthy adults. (2014) (44)
- Normal cortisol response to high-dose synacthen and insulin tolerance test in children and adults with Prader-Willi syndrome. (2010) (43)
- Course of diabetic nephropathy. Factors related to development. (1981) (42)
- Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men (2011) (42)
- Limitations to subcutaneous insulin administration in type 1 diabetes (2003) (42)
- The effect of glucagon infusion on kidney function in short-term insulin-dependent juvenile diabetics (1980) (42)
- Growth hormone secretory capacity and serum insulin-like growth factor I levels in primary infertile, anovulatory women with regular menses. (1992) (41)
- OPPORTUNITY™: a large-scale randomized clinical trial of growth hormone in hemodialysis patients. (2011) (41)
- Impact of 2 weeks high dose growth hormone treatment on basal and insulin stimulated substrate metabolism in humans (1993) (41)
- The effects of GH and hormone replacement therapy on serum concentrations of mannan-binding lectin, surfactant protein D and vitamin D binding protein in Turner syndrome. (2004) (40)
- The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus (1981) (40)
- The comparison of venous plasma glucose and whole blood capillary glucose in diagnoses of Type 2 diabetes: a population‐based screening study (2005) (40)
- Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: impact of GH treatment. (2001) (40)
- Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study (2012) (39)
- Effect on renal haemodynamics, glomerular filtration rate and albumin excretion of high oral protein load. (1986) (39)
- Effect of continuous subcutaneous insulin infusion on kidney function and size in IDDM patients: a 2 year controlled study. (1987) (39)
- Adult growth hormone deficiency. (2021) (38)
- Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults. (2011) (38)
- OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients. (2008) (38)
- Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients. (2003) (38)
- Determinants of 24-H Blood Pressure in IDDM Patients (1995) (37)
- Twice‐daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin‐naïve adults with Type 2 diabetes (2015) (37)
- Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study (2013) (37)
- Acute exposure to GH during exercise stimulates the turnover of free fatty acids in GH-deficient men. (2004) (36)
- Pathophysiology‐based phenotyping in type 2 diabetes: A clinical classification tool (2018) (36)
- Effect of growth hormone and 17β‐oestradiol treatment on metabolism and body composition in girls with Turner syndrome (2005) (36)
- Rates of Community-based Antibiotic Prescriptions and Hospital-treated Infections in Individuals With and Without Type 2 Diabetes: A Danish Nationwide Cohort Study, 2004-2012. (2016) (36)
- Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project cohort of newly diagnosed patients with type 2 diabetes: a cohort profile (2018) (36)
- Letter: Diagonal ear-lobe crease in coronary heart disease. (1975) (35)
- Type I and III procollagen propeptides in growth hormone-deficient patients: effects of increasing doses of GH. (1991) (35)
- Growth Hormone Treatment in Adults with Adult‐Onset Growth Hormone Deficiency Increases Iliac Crest Trabecular Bone Turnover: A 1‐Year, Double‐Blind, Randomized, Placebo‐Controlled Study (2000) (35)
- Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome. (2012) (35)
- Vitamin D metabolism in insulin-dependent diabetes mellitus. (1983) (34)
- Combined Heart Rate– and Accelerometer-Assessed Physical Activity Energy Expenditure and Associations With Glucose Homeostasis Markers in a Population at High Risk of Developing Diabetes (2013) (34)
- Inhibin A and B in adolescents and young adults with Turner's syndrome and no sign of spontaneous puberty. (2002) (34)
- Growth hormone replacement in adults - current standards and new perspectives. (2015) (33)
- Free and total insulin-like growth factors and insulin-like growth factor binding proteins during 14 days of growth hormone administration in healthy adults. (1996) (33)
- Delayed β-cell response and glucose intolerance in young women with Turner syndrome (2011) (33)
- Impact of body composition on very-low-density lipoprotein-triglycerides kinetics. (2009) (33)
- Influence of growth hormone and androgens on body composition in adults. (1996) (33)
- Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study (2011) (33)
- The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy. (1999) (33)
- Associations between Ultrasound Measures of Abdominal Fat Distribution and Indices of Glucose Metabolism in a Population at High Risk of Type 2 Diabetes: The ADDITION-PRO Study (2015) (33)
- Serum free insulin-like growth factor-I in growth hormone-deficient adults before and after growth hormone replacement. (1997) (32)
- Subclinical left ventricular dysfunction in normotensive women with Turner’s syndrome (2006) (32)
- Effects of growth hormone on body composition in adults. (1990) (32)
- Estradiol acutely inhibits whole body lipid oxidation and attenuates lipolysis in subcutaneous adipose tissue: a randomized, placebo-controlled study in postmenopausal women. (2012) (32)
- On the pathogenesis of the increased glomerular filtration rate in short-term insulin-dependent diabetes. (1984) (32)
- Continuation of growth hormone (GH) substitution during fasting in GH-deficient patients decreases urea excretion and conserves protein synthesis. (2001) (32)
- Exercise, hormones, and body temperature. Regulation and action of GH during exercise (2003) (32)
- Pharmacological aspects of growth hormone replacement therapy: route, frequency and timing of administration. (1990) (31)
- Microalbuminuria in diabetic patients--a longitudinal study. (1981) (31)
- The effect of growth hormone on the insulin-like growth factor system during fasting. (2003) (31)
- Serum concentrations of insulin-like growth factors (IGFs), IGF binding proteins 1 and 3 and growth hormone binding protein in obese women and the effects of growth hormone administration: a double-blind, placebo-controlled study. (1995) (31)
- Energy expenditure, insulin, and VLDL-triglyceride production in humans Published, JLR Papers in Press, July 18, 2006. (2006) (31)
- Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism. (2005) (30)
- Two years of growth hormone treatment in adults with Prader-Willi syndrome do not improve the low BMD. (2013) (30)
- The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) study: implementation of a nationwide patient enrollment system (2012) (30)
- Growth hormone and body composition. (1996) (30)
- GH-replacement therapy in adults. (1991) (30)
- Differential effects of growth hormone and prednisolone on energy metabolism and leptin levels in humans. (1998) (30)
- Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status (2007) (29)
- Determinants of intra-individual variation in kidney function in normoalbuminuric insulin-dependent diabetic patients: importance of atrial natriuretic peptide and glycaemic control. (1992) (29)
- Impact of insulin antibodies on insulin aspart pharmacokinetics and pharmacodynamics after 12-week treatment with multiple daily injections of biphasic insulin aspart 30 in patients with type 1 diabetes. (2005) (29)
- Effect of Guar Gum on 24-hour Insulin Requirements of Insulin-dependent Diabetic Subjects as Assessed by an Artificial Pancreas (1980) (29)
- Cardiovascular effects of GH. (1997) (29)
- A multistep algorithm for processing and calibration of microdialysis continuous glucose monitoring data. (2013) (29)
- Renal and glycemic determinants of glomerular hyperfiltration in normoalbuminuric diabetics. (1990) (29)
- Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting. (2004) (28)
- Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial (2018) (28)
- Body fluids, circadian blood pressure and plasma renin during growth hormone administration: a placebo-controlled study with two growth hormone doses in healthy adults. (1995) (28)
- Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency. (1996) (28)
- Influence of insulin and free fatty acids on contractile function in patients with chronically stunned and hibernating myocardium. (2005) (27)
- Lower rates of hypoglycemia during maintenance treatment with insulin degludec/insulin aspart versus biphasic insulin aspart 30: a combined analysis of two Phase 3a studies in type 2 diabetes (2016) (27)
- Insulin and GH Signaling in Human Skeletal Muscle In Vivo following Exogenous GH Exposure: Impact of an Oral Glucose Load (2011) (27)
- Microalbuminuria: studies in diabetes, essential hypertension, and renal diseases as compared with the background population. (1991) (27)
- Functional and morphological renal manifestations in diabetes mellitus (1981) (27)
- Growth Hormone (GH)-Deficiency in Adults: Clinical Features and Effects of GH Substitution (1994) (27)
- Pegylated long-acting human growth hormone possesses a promising once-weekly treatment profile, and multiple dosing is well tolerated in adult patients with growth hormone deficiency. (2011) (27)
- Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis. (2006) (27)
- The role of nitric oxide in L-arginine-stimulated growth hormone release. (1999) (27)
- Independent Effects of Testosterone on Lipid Oxidation and VLDL-TG Production (2013) (26)
- Resting metabolic rate in healthy adults: relation to growth hormone status and leptin levels. (1998) (26)
- Sex Steroids and the Growth Hormone/Insulin-Like Growth Factor-I Axis in Adults (2005) (26)
- Regulation of uncoupling protein-2 and -3 by growth hormone in skeletal muscle and adipose tissue in growth hormone-deficient adults. (1999) (26)
- Postprandial VLDL-triacylglycerol secretion is not suppressed in obese type 2 diabetic men (2012) (26)
- Marked reductions in bioactive insulin-like growth factor I (IGF-I) during hemodialysis. (2010) (25)
- Ambulatory Arterial Stiffness Index in Turner Syndrome: The Impact of Sex Hormone Replacement Therapy (2008) (25)
- Prescribing practices and clinical predictors of glucose‐lowering therapy within the first year in people with newly diagnosed Type 2 diabetes (2015) (25)
- Effects of growth hormone administration on protein dynamics and substrate metabolism during 4 weeks of dietary restriction in obese women (2000) (25)
- Comparison Between One-Point Calibration and Two-Point Calibration Approaches in a Continuous Glucose Monitoring Algorithm (2014) (25)
- Variability in growth hormone stimulation tests. (1998) (24)
- The effect of growth hormone (GH) replacement on blood glucose homeostasis in adult nondiabetic patients with GH deficiency: real‐life data from the NordiNet® International Outcome Study (2017) (24)
- Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol. (1997) (24)
- A phase 2 trial of long-acting TransCon growth hormone in adult GH deficiency (2017) (23)
- Kidney function and size in type 1 (insulin-dependent) diabetic patients before and during growth hormone administration for one week (1982) (23)
- Growth hormone treatment during pregnancy in a growth hormone-deficient woman. (1995) (23)
- Diurnal plasma profiles of metabolite and hormone concentration in insulin-dependent diabetic patients during conventional insulin treatment and continuous subcutaneous insulin infusion. A controlled study. (1987) (23)
- Visceral fat mass is a strong predictor of circulating ghrelin levels in premenopausal women. (2009) (23)
- Impaired growth hormone secretion and increased growth hormone-binding protein levels in subfertile males. (1996) (23)
- The effect of submaximal exercise on immuno- and bioassayable IGF-I activity in patients with GH-deficiency and healthy subjects. (2005) (22)
- Effects of growth hormone (GH) administration on functional hepatic nitrogen clearance: studies in normal subjects and GH-deficient patients. (1994) (22)
- Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone. (1999) (21)
- Growth hormone administration by means of an injection pen. (1989) (21)
- Patient reported outcome in posttraumatic pituitary deficiency: results from The Danish National Study on posttraumatic hypopituitarism. (2015) (21)
- Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial. (2016) (21)
- Effects of captopril on ambulatory blood pressure, renal and cardiac function in microalbuminuric type 1 diabetic patients. (1994) (21)
- Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis. (2005) (21)
- Acute and short-term chronic testosterone fluctuation effects on glucose homeostasis, insulin sensitivity, and adiponectin: a randomized, double-blind, placebo-controlled, crossover study. (2014) (21)
- Reduced Subendocardial Viability Ratio Is Associated With Unfavorable Cardiovascular Risk Profile in Women With Short Duration of Type 2 Diabetes. (2016) (21)
- Echocardiographic-determined left ventricular wall characteristics in insulin-dependent diabetic patients. (2009) (21)
- Serum Insulin-Like Growth Factor I Levels in Growth Hormone-Deficient Adults: Influence of Sex Steroids (2005) (21)
- Continuous Subcutaneous Glucose Monitoring Shows a Close Correlation between Mean Glucose and Time Spent in Hyperglycemia and Hemoglobin A1c (2007) (20)
- ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment. (1991) (20)
- Assessment of postprandial glucose excursions throughout the day in newly diagnosed type 2 diabetes. (2013) (20)
- Growth hormone replacement does not increase mortality in patients with childhood‐onset growth hormone deficiency (2015) (20)
- Ten Years of Experience with Biphasic Insulin Aspart 30 (2012) (20)
- Clinical Evaluation of a Transcutaneous Interrogated Fluorescence Lifetime-Based Microsensor for Continuous Glucose Reading (2009) (20)
- Somatopause and adiposity. (1997) (20)
- Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study. (1998) (19)
- Stimulation of the 150-kilodalton insulin-like growth factor-binding protein-3 ternary complex by continuous and pulsatile patterns of growth hormone (GH) administration in GH-deficient patients. (2000) (19)
- Bioavailability and bioactivity of intravenous vs subcutaneous infusion of growth hormone in GH‐deficient patients (1996) (19)
- Long-term effects of growth hormone (GH) on body fluid distribution in GH deficient adults: a four months double blind placebo controlled trial. (1999) (18)
- Accuracy evaluation of a new real-time continuous glucose monitoring algorithm in hypoglycemia. (2014) (18)
- The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT. (2006) (18)
- Body composition and circulating levels of insulin, insulin-like growth factor-binding protein-1 and growth hormone (GH)-binding protein affect the pharmacokinetics of GH in adults independently of age. (2002) (18)
- Rapid changes in kidney function--factors influencing kidney function in diabetics and normal man. (1981) (18)
- Effect of pump versus pen treatment on glycaemic control and kidney function in long-term uncomplicated insulin-dependent diabetes mellitus (IDDM). (1989) (17)
- Vitamin C treatment reduces transcapillary escape rate of albumin in type 1 diabetes. (2004) (17)
- Different Effects of Continuous and Intermittent Patterns of Growth Hormone Administration on Lipoprotein Levels inGrowth Hormone-Deficient Patients (1998) (17)
- Metabolic consequences of GH deficiency. (2005) (17)
- Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I. (2005) (17)
- The relationship between pregnancy, HCS and B lymphocytes. (2009) (17)
- Reversible Albumin-Binding GH Possesses a Potential Once-Weekly Treatment Profile in Adult Growth Hormone Deficiency. (2016) (16)
- Renal function in diabetic rats. (1981) (16)
- Fuel metabolism in growth hormone-deficient adults. (1995) (16)
- The metabolic clearance rate, serum half-time and apparent distribution space of authentic biosynthetic human growth hormone in growth hormone-deficient patients. (1989) (16)
- Growth hormone (GH) therapy in GH-deficient patients, the plasma factor VIII-von Willebrand factor complex, and capillary fragility. A double-blind, placebo-controlled crossover study. (1990) (16)
- Impact of Growth Hormone Administration on Other Hormonal Axes (1999) (16)
- Kidney function in acromegaly. (2009) (15)
- Mortality and socioeconomic status in adults with childhood onset GH deficiency (GHD) is highly dependent on the primary cause of GHD. (2012) (15)
- Lifestyle and clinical factors associated with elevated C-reactive protein among newly diagnosed Type 2 diabetes mellitus patients: a cross-sectional study from the nationwide DD2 cohort (2014) (15)
- The growth hormone (GH)-insulin-like growth factor axis during testosterone replacement therapy in GH-treated hypopituitary males. (2001) (15)
- A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design (2012) (15)
- Serum leptin concentrations during short-term administration of growth hormone and triiodothyronine in healthy adults: a randomised, double-blind placebo-controlled study. (1999) (15)
- IDegAsp: a novel soluble insulin analogs combination (2012) (15)
- Socioeconomic factors do not but GH treatment does affect mortality in adult-onset growth hormone deficiency. (2014) (15)
- Glucose homeostasis in adults with Prader-Willi syndrome during treatment with growth hormone: results from a 12-month prospective study. (2014) (15)
- Low Physical Activity Is Associated With Increased Arterial Stiffness in Patients Recently Diagnosed With Type 2 Diabetes. (2016) (15)
- Reproducibility of pulse wave analysis and pulse wave velocity in patients with type 2 diabetes (2013) (15)
- Increased disorderliness and decreased mass and daily rate of endogenous growth hormone secretion in adult Turner syndrome: the impact of body composition, maximal oxygen uptake and treatment with sex hormones. (1998) (14)
- Evaluation of growth hormone stimulation tests in cured acromegalic patients. (2003) (14)
- Renal changes in long-term Type 1 (insulin-dependent) diabetic patients with and without clinical nephropathy: a light microscopic, morphometric study of autopsy material (1984) (14)
- Plasma levels of the arterial wall protein fibulin-1 are associated with carotid-femoral pulse wave velocity: a cross-sectional study (2013) (14)
- Growth hormone (GH) substitution for one year normalizes elevated GH-binding protein levels in GH-deficient adults secondary to a reduction in body fat. A placebo-controlled trial. (1998) (14)
- Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes (2016) (14)
- Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study (2014) (14)
- Subcutaneous degradation of insulin (1981) (14)
- Effects of lowering circulating free fatty acid levels on protein metabolism in adult growth hormone deficient patients. (2002) (14)
- Morning blood pressure surge and target organ damage in newly diagnosed type 2 diabetic patients: a cross sectional study (2015) (14)
- Unchanged renal haemodynamics following high dose ascorbic acid administration in normoalbuminuric IDDM patients. (1995) (14)
- Nasal Absorption of Growth Hormone in Normal Subjects: Studies with Four Different Formulations (1994) (13)
- L-arginine-induced growth hormone secretion is not influenced by co-infusion of the nitric oxide synthase inhibitor N-monomethyl-L-arginine in healthy men. (1998) (13)
- Glomerular hyperfiltration in diabetes mellitus. (1985) (13)
- Similar VLDL-TG Storage in Visceral and Subcutaneous Fat in Obese and Lean Women (2011) (13)
- A comparison of pharmacokinetics and pharmacodynamics of insulin aspart, biphasic insulin aspart 70, biphasic insulin aspart 50, and human insulin: a randomized, quadruple crossover study. (2012) (13)
- Association of parental history of type 2 diabetes with age, lifestyle, anthropometric factors, and clinical severity at type 2 diabetes diagnosis: results from the DD2 study (2016) (13)
- Subcutaneous Absorption Kinetics of Two Highly Concentrated Preparations of Recombinant Human Growth Hormone (1993) (13)
- Growth Hormone Therapy in Adults (2001) (13)
- Comparison of 24-hour insulin requirements in IDDM patients during control by an artificial betacell and during conventional therapy. (1981) (12)
- Interindividual and Intraindividual Variations in Postprandial Glycemia Peak Time Complicate Precise Recommendations for Self-Monitoring of Glucose in Persons with Type 1 Diabetes Mellitus (2012) (12)
- A comparison of pharmacokinetics and pharmacodynamics of biphasic insulin aspart 30, 50, 70 and pure insulin aspart: a randomized, quadruple crossover study. (2009) (12)
- Effects of growth hormone on serum lipids and lipoproteins: possible significance of increased peripheral conversion of thyroxine to triiodothyronine. (1996) (12)
- Overnight CSII as supplement to oral antidiabetic drugs in Type 2 diabetes (2008) (12)
- The effect of long-term pharmacological antilipolysis on substrate metabolism in growth hormone (GH)-substituted GH-deficient adults. (2002) (12)
- Mortality and Reduced Growth Hormone Secretion (2007) (12)
- GH stimulation tests: evaluation of GH responses to heat test versus insulin-tolerance test. (1998) (12)
- Effects of a 7-day continuous infusion of octreotide on circulating levels of growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients. (1999) (12)
- Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled study. (2000) (12)
- Effect of growth hormone administration on circulating levels of luteinizing hormone, follicle stimulating hormone and testosterone in normal healthy men. (1993) (11)
- Exercise capacity and cardiac function in type 1 diabetic patients treated with continuous subcutaneous insulin infusion. A controlled study. (1986) (11)
- Insulin-like growth factors (IGF) I and II and IGF binding proteins 1, 2 and 3 during low-dose growth hormone (GH) infusion and sequential euglycemic and hypoglycemic glucose clamps: studies in GH-deficient patients. (1993) (11)
- Short-term effects of NPH insulin, insulin detemir, and insulin glargine on the GH-IGF1-IGFBP axis in patients with type 1 diabetes. (2014) (11)
- 35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
- Smoking and glycaemic control in male insulin dependent (type 1) diabetics. (1984) (11)
- Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION-Denmark trial (2014) (11)
- Determination of 24-hour insulin infusion pattern by an artificial endocrine pancreas for intravenous insulin infusion with a miniature pump. (1981) (10)
- Lack of impact of pharmacological growth hormone administration on circulating levels of reproductive hormones during the menstrual cycle in normal women. (1993) (10)
- The Efficacy and Safety of Long-term Norditropin® Treatment in Children with Prader-Willi Syndrome (2013) (10)
- Glycemia, lipidemia and systolic left ventricular function evaluated by myocardial strain rate: a tissue Doppler echocardiographic study. (2008) (10)
- Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patients. (2013) (10)
- Long-Acting Growth Hormone (2013) (10)
- Continuation of growth hormone therapy versus placebo in transition-phase patients with growth hormone deficiency: impact on body composition, insulin sensitivity, and thyroid function. (2002) (9)
- The renin-angiotensin system and kidney function during initial insulin treatment in diabetic man. (1988) (9)
- Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator). (1979) (9)
- The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Project: rationale and planned nationwide studies of genetic predictors, physical exercise, and individualized pharmacological treatment (2012) (9)
- Serum osteocalcin and bone isoenzyme alkaline phosphatase in growth hormone-deficient patients: Dose-response studies with biosynthetic human GH (1991) (9)
- Intensifying existing premix therapy (BIAsp 30) with BIAsp 50 and BIAsp 70: A consensus statement (2011) (9)
- Self-Monitoring of Blood Glucose—Epidemiological and Practical Aspects (2008) (9)
- Biochemical markers of bone turnover in tibia fracture patients randomly assigned to growth hormone (GH) or placebo injections: Implications for detection of GH abuse. (2011) (9)
- An artificial betacell: assessment of the glucose analyser, infusion system and optimization of constants for the algorithms. (1981) (8)
- Near normoglycemia for 1 year has no effect on platelet reactivity, factor VIII, and von Willebrand factor in insulin-dependent diabetes mellitus: a controlled trial. (1987) (8)
- Changes in glycaemic control are related to the systolic function in type 1 diabetes mellitus. (2007) (8)
- Metabolic effects of GH: a rationale for continued GH treatment of GH-deficient adults after cessation of linear growth. (1995) (8)
- 24-hour blood glucose profiles in insulin-dependent diabetics treated with intravenous insulin infusion systems. A comparison between closed- and open-loop systems. (2009) (8)
- GLP-1 infusion reduces IGFBP-1 serum level in humans. (2014) (8)
- Low myocardial glucose uptake in Turner syndrome is unaffected by growth hormone: a randomized, placebo‐controlled FDG‐PET study (2015) (8)
- Absorption kinetics of two highly concentrated preparations of growth hormone: 12 IU/ml compared to 56 IU/ml. (1994) (7)
- Glucagon responses to intravenous arginine and oral glucose in insulin-dependent diabetic patients during six months conventional or continuous subcutaneous insulin infusion. (1988) (7)
- Low-dose dopamine infusion, renal haemodynamics and urinary albumin excretion rate in insulin-dependent diabetics and in normal man. (1988) (7)
- Bioavailability of recombinant human growth hormone in different concentrations and formulations. (1996) (7)
- The management of adult growth hormone deficiency syndrome (2008) (7)
- Clinical aspects of growth hormone deficiency in adults. An overview. (2005) (7)
- Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes (2014) (7)
- The management of adult growth hormone deficiency syndrome. (2008) (7)
- Early Renal Hyperfunction and Hypertrophy in Insulin-Dependent Patients: Changes Found at Diagnosis and Early in the Course of Diabetes (1988) (6)
- Biochemical markers of bone turnover in tibia fracture patients randomly assigned to growth hormone (GH) or placebo injections ☆ ☆☆ ★: Implications for detection of GH abuse (2010) (6)
- Somatropin and Glucose Homeostasis (2002) (6)
- Repeated screening for albumin-creatinine ratio in an unselected population. The Ebeltoft Health Promotion Study, a randomized, population-based intervention trial on health test and health conversations with general practitioners. (1994) (6)
- Hypertension and Diabetic Nephropathy. (2016) (6)
- Measurement of free GH and bioactive IGF-I in non-diabetic haemodialysis patients treated with GH for 7 days. (2012) (6)
- OR03-5 A phase 2, multicenter, multiple-dose, open-label, parallel-group, active controlled, safety, tolerability, pharmacokinetic and pharmacodynamic study of ACP-001 in adult patients with Growth Hormone Deficiency (AGHD) (2012) (6)
- Lipoprotein changes during continuous subcutaneous insulin infusion in insulin-dependent diabetic patients. (1986) (6)
- Protein metabolism in Turner syndrome and the impact of hormone replacement therapy (2007) (5)
- Pharmacokinetic aspects of insulin therapy — with special reference to pumps and pens versus conventional insulin treatment (1990) (5)
- The Effect of Weight Loss on Serum Mannose-Binding Lectin Levels (2009) (5)
- Short-Term Tools to Measure Responsiveness to Growth Hormone Replacement (2004) (5)
- Serum growth hormone (GH) profiles after nasally administered GH in normal subjects and GH deficient patients (1994) (5)
- [The GCP-unit at the Aaarhus University Hospital]. (2000) (5)
- Impaired postprandial response of the insulin‐like growth factor system in maintenance haemodialysis (2014) (5)
- Effects of octreotide on insulin-like growth factor I and metabolic indices in growth hormone-treated growth hormone-deficient patients. (1993) (4)
- The effect of short‐term near‐normal blood glucose control on oscillatory potential and macular recovery time in insulin‐dependent diabetic patients with long‐standing metabolic dysregulation (1989) (4)
- The blood‐retinal barrier permeability to fluorescein in juvenile diabetics treated with continuous subcutaneous insulin infusion (1985) (4)
- PO126 IDEGASP LOWERS THE RATE OF HYPOGLYCEMIA VS BIPHASIC INSULIN ASPART 30 IN ADULTS WITH T2D ACHIEVING GLYCEMIC TARGET (HBA1C <7.0%): A META-ANALYSIS (2014) (4)
- [Sexual dysfunction in diabetes mellitus]. (2002) (4)
- The Epidemiology of Growth Hormone Deficiency (2011) (4)
- Consequences of stopping growth hormone (GH) therapy in young GH deficient patients with childhood onset disease. (1998) (4)
- Type 2-diabetes. Medicinsk teknologivurdering af screening, diagnostik og behandling (2003) (4)
- Explorative Study of Pharmacokinetics and Pharmacodynamics after Change in Basal Insulin Infusion Rate (2011) (4)
- Brave new senescence: GH in adults. (1993) (4)
- Cardiovascular effects of growth hormone--with special reference to growth hormone replacement therapy. (1992) (4)
- Letter: diagonal ear-lobe crease and diabetic retinal angiopathy. (1976) (3)
- Overnight versus 24 Hours of Continuous Subcutaneous Insulin Infusion as Supplement to Oral Antidiabetic Drugs in Type 2 Diabetes (2007) (3)
- Bone markers and growth hormone (GH) abuse in athletes (1998) (3)
- [Guidelines on diagnosis of type 2 diabetes. Investigation, diagnosis and glucose measurement]. (2003) (3)
- Assessment of hydration by means of bioelectrical impedance and arm muscle area during growth hormone (GH) replacement therapy: A prospective study of 130 GH-deficient patients. (2007) (3)
- 97 THE ABSORPTION KINETICS OF SUBCUTANEOUSLY ADMINISTERED GRWOTH HORMONE: INFLUENCE OF INJECTION VOLUME (1988) (3)
- PO231 IDEGASP PROVIDES SUPERIOR FPG CONTROL AND REDUCED HYPOGLYCEMIA VS BIASP 30 IN INSULIN-NAIVE ADULTS WITH TYPE 2 DIABETES: A RANDOMIZED PHASE 3 TRIAL (2014) (3)
- The potential for improvement of outcomes by personalized insulin treatment of type 1 diabetes as assessed by analysis of single-patient data from a randomized controlled cross-over insulin trial. (2017) (3)
- Impact of moderate interval exercise versus supine rest on the pharmacokinetics and pharmacodynamic profiles of subcutaneously administered growth hormone in adult growth hormone deficient patients. (2014) (3)
- Defining growth hormone deficiency in adults: a matter of specificity (1994) (3)
- Natural history of hypertension and kidney disease in diabetes (1990) (3)
- PDB43 PATIENT REPORTED OUTCOMES ARE SUPERIOR IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LIRAGLUTIDE AS COMPARED TO EXENATIDE, WHEN ADDED TO METFORMIN, SULFONYLUREA OR BOTH (2009) (2)
- A novel algorithm for processing and calibrating continuous glucose monitoring data (2012) (2)
- Effects of human insulin and insulin aspart preparations on levels of IGFI, IGFBPs and IGFI bioactivity in patients with type 1 diabetes (2013) (2)
- Effects of GH replacement in young patients with childhood onset GH deficiency. (2002) (2)
- Growth hormone deficiency in adults (2005) (2)
- Growth hormone treatment in adults: is there a true gender difference? (2001) (2)
- Dilation of ascending aorta in Turner syndrome - short-term follow-up (2010) (2)
- [Insulin pump treatment in Denmark]. (2004) (2)
- Some aspects of antihypertensive and diuretic treatment in noninsulin-dependent diabetic patients. (1990) (2)
- Left ventricular wall mass and wall thickness in insulin dependent diabetic patients without clinical signs of ischaemic heart disease. (1988) (2)
- Interaction between exogenous insulin, endogenous insulin, and glucose in type 2 diabetes patients. (2015) (2)
- Biochemical definitions of disease activity in acromegaly. (2003) (2)
- IDegAsp (insulin degludec + insulin aspart) for the management of type 2 diabetes: current status (2016) (2)
- Closed-loop system in evaluation of insulin infusion rates for an open-loop system. (1979) (2)
- FERTILITY AND SEMEN QUALITY IN PREVIOUSLY GROWTH HORMONE TREATED MEN (1988) (2)
- Growth Hormone Treatment of Nonelderly Adults with GH Deficiency (1995) (2)
- Isolated hyperglycaemia does not increase VLDL-triacylglycerol secretion in type 1 diabetic men (2015) (2)
- Somatropin and glucose homeostasis: considerations for patient management. (2002) (2)
- OR7-1: A reversible albumin-binding GH derivative possesses a promising once-weekly treatment profile and is well tolerated in adult subjects with growth hormone deficiency (2014) (1)
- Menstrual Cycle Interaction with the Growth Hormone Axis (1999) (1)
- Effects of Growth Hormone on Body Fluid Homeostasis (1992) (1)
- Local Tolerability of Insulin Degludec is Comparable to Insulin Glargine: A Meta-analysis of T1DM and T2DM (2012) (1)
- Effect of Continuous Glucose Monitoring Accuracy on Clinicians’ Retrospective Decision Making in Diabetes (2015) (1)
- Diet versus average Danish food in insulin-dependent diabetes mellitus. An evaluation during treatment with an artificial betacell. (1982) (1)
- The Heart in Diabetic Nephropathy (1992) (1)
- Clinical outcome of using insulin at 40 IU/ml and 100 IU/ml in pump treatment. Results of a controlled multi-center trial. (2009) (1)
- Insulin aspart: rapid control for postmeal glucose excursions (2007) (1)
- Serum Insulin Aspart Concentrations following High-Dose Insulin Aspart Administered Directly into the Duodenum of Healthy Subjects: An Open-Labeled, Single-Blinded, and Uncontrolled Exploratory Trial (2009) (1)
- Effect of short-term IGF-I administration on sperm motility and seminal plasma IGF-I in young healthy males (1998) (1)
- GH therapy has a beneficial effect on HbA1c levels in adult patients with GH deficiency: a report from the NordiNet[reg] International Outcome Study (2015) (1)
- Growth Hormone and Insulin Resistance (2007) (1)
- Acute renal effects of angiotensin converting enzyme inhibition in microalbuminuric type 1 diabetic patients (2004) (1)
- [Self-determination of blood glucose in insulin-dependent diabetes mellitus]. (1980) (1)
- Temporal trends in use of evidence-based treatments and risk factor control: a decade of nationwide monitoring (2014) (1)
- P02-46 Diurnal variation in the pharmacokinetics of growth hormone administered as a continuous subcutaneous infusion in GH-deficient subjects (2012) (1)
- Lipoproteins and diuretics in type II diabetes. (1991) (1)
- ACTH stimulation test in patients with type 1 diabetes and recurrent severe hypoglycaemia (2015) (1)
- Autoimmune thyrotoxicosis developed during growth hormone (GH) treatment of an adult with childhood onset GH-deficiency. A causal relationship? (1998) (1)
- [Soft tissue changes in adults with acquired growth hormone deficiency during substitution treatment. A double-blind, randomized, placebo-controlled study after a year of treatment]. (1997) (1)
- Body Composition : Results from a Randomized , Placebo-Controlled One Year of Growth Hormone Treatment in Adults with Prader-Willi Syndrome (2010) (1)
- Multi disciplinary preventive effort to diabetic patients in the primary and secondary health care system (2000) (0)
- OR7,38 Measurement of free GH and bioactive IGF-I in non-diabetic hemodialysis patients treated with rh-GH for 7 days (2010) (0)
- The prevalence of insufficient test responses in patients with traumatic brain injury compared to healthy controls [ndash] results from The Danish National Study on posttraumatic hypopituitarism (2013) (0)
- The tenth hGH symposium, Seville, April 23-24, 1999 (1999) (0)
- Comment and reply on: Insulin therapy in type 2 diabetes: insulin analogue mix 50, a potential role in reducing postprandial hyperglycaemia and cardiovascular disease (2010) (0)
- OR05-3 LONG TERM GROWTH HORMONE ADMINISTRATION TO HEALTHY SUBJECTS WITH FRACTURES INDUCE A MARKED AND SUSTAINED INCREASE IN CIRCULATING MARKERS OF BONE METABOLISM (2006) (0)
- TO001 MONITORING OF BKV LOAD IN URINE ALLOWS IDENTIFICATION OF PATIENTS WITH THE HIGH RISK FOR BKV-ASSOCIATED NEPHROPATHY SEVERAL WEEKS PRIOR TO DEVELOPMENT OF VIREMIA: ANALYSIS OF 4128 URINE AND SERUM SAMPLES (2008) (0)
- Growth hormone conserves nitrogen andaccelerates lipolysis during dietary restriction in obese women (1999) (0)
- Poster presentation: Assessment of Postprandial Glucose Excursions Throughout the Day in Newly Diagnosed Type 2 Diabetes (2012) (0)
- hGH Symposium: 5th Symposium, Paris, April 1994 (1994) (0)
- Ascending aortic dilatation in Turner syndrome: the natural history (2010) (0)
- No influence of prednisolone induced catabolism on IGFBP-3 proteolysis in healthy young men (2000) (0)
- P-44 Gender related IGF-I changes after two years of growth hormone (GH) treatment in GH deficient (GHD) children and adults. Data from the NordiNet® International Outcome Study (IOS) (2008) (0)
- Growth hormone administration conserves nitrogen and accelerates lipolysis during dietary restriction in obese subjects (1998) (0)
- Growth Hormone (GH) Treatment in GH-Deficient Adults; Therapeutic and Diagnostic Aspects (1994) (0)
- P-98 FREE FATTY ACID (FFA) INFUSION ACUTELY AND REVERSIBLY SUPPRESSES SERUM GHRELIN LEVELS (2006) (0)
- [Growth hormone deficiency in adults--clinical picture and treatment]. (1995) (0)
- P28 Insulin resistance induced by GH is transient and reversible: glucose clamp studies during different ambient GH levels in GH-deficient adults (2010) (0)
- [203] IGF-1 SUPPLEMENTATION DOES NOT IMPROVE INSULIN ACTION IN CIRRHOSIS (2007) (0)
- Intravenous constant ghrelin infusion in healthy young men: sustained cardiovascular effects of supraphysiological ghrelin levels (2007) (0)
- Related articles (2012) (0)
- ABSORPTION KINETICS AND METABOLIC EFFECTS OF GH FOLLOWING SUBCUTANEOUS INJECTIONS IN THE ABDOMEN VERSUS THE THIGH (1993) (0)
- hGH Symposium: 6th Symposium, London, April 1995 (1996) (0)
- The 11th hGH Symposium, Sorrento, March 30-April 2, 2000 (2000) (0)
- Subject Index Vol. 62, Suppl. 3, 2004 (2004) (0)
- Effects of insulin-like growth factor-I on glucose metabolism and hepatic amino acid-N conversion in patients with liver cirrhosis (2001) (0)
- OR05-5 MORBIDITY IN GROWTH HORMONE DEFICIENCY — A NATIONWIDE STUDY (2006) (0)
- Targets for the managent of diabetes 2011 (2011) (0)
- [Preservation and regeneration of residual function of the beta cells in insulin-dependent diabetics]. (1981) (0)
- 28Th International Symposium on GH and Growth Factors in Endocrinology and Metabolism (2000) (0)
- Kidney function, hypertension and clinical diabetic nephropathy in type 1 diabetes (1991) (0)
- [Increased working capacity in insulin-dependent diabetics treated with insulin pumps. A controlled study]. (1988) (0)
- Protein metabolism in a model of premature ovarian failure, Turner syndrome, and the impact of hormone replacement therapy (2007) (0)
- hGH Symposium: 8th Symposium, Mannheim, April 1997 (1997) (0)
- GROWTH HORMONE (GH) DEFICIENCY IN ADULTHOOD: SHORT AND LONG TERM EFFECTS OF GH SUBSTITUTION (1993) (0)
- The E ffi cacy and Safety of Long-term Norditropin ® Treatment in Children with Prader-Willi Syndrome (2013) (0)
- Determinants of IGF-I in adult turner syndrome: The influence of sex hormones and GH (1998) (0)
- The effect of a physiological growth hormone pulse on lipolysis in abdominal and femoral adipose tissue assessed by microdialysis (1998) (0)
- OR7,42 Serum proteomic profiles in GH-deficient patients before and after GH substitution (2010) (0)
- REACH further (2011) (0)
- OR6,4 Marked reductions in bioactive IGF-I during hemodialysis (2008) (0)
- Increased alanine aminotransferase levels and associated characteristics among newly diagnosed type 2 diabetes patients: Results from the DD2 study (2013) (0)
- Subcutaneous continuous glucose monitoring reveals insight into long-term management of diabetes through a tight correlation of time spent in hyperglycemia vs. HbA1c. (2002) (0)
- [Prognosis for juvenile diabetics with nephropathy and renal failure]. (1977) (0)
- P12 Norditropin increases lean muscle, reduces fat mass and normalizes height in children with Prader-Willi Syndrome (2010) (0)
- [Old knowledge about obesity and diabetes]. (2001) (0)
- [Glomerular hyperfiltration during sugar diabetes]. (1985) (0)
- STATUS: THE DANISH CENTER FOR STRATEGIC REASEARCH IN TYPE 2 DIABETIS - THE DD2 STUDY (2013) (0)
- hGH Symposium: 11th Symposium, Sorrento, March-April 2000 (2000) (0)
- The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Study Cohort: Presentation of 5,870 Patients with New Type 2 Diabetes Enrolled from 2010 Through 2014 (2016) (0)
- Growth Hormone and Endocrinology: 16th Novo Nordisk Symposium, Vienna, April 2005: Proceedings (2005) (0)
- Insulin-like growth factor-I improves glucose metabolism and hepatic amino acid-N conversion in patients with liver cirrhosis (2000) (0)
- Pioglitazone modifies the effects of growth hormone on lipolysis and insulin sensitivity (2007) (0)
- Subject Index Vol. 64, Suppl. 2, 2005 (2005) (0)
- Subject Index Vol. 68, Suppl. 5, 2007 (2007) (0)
- hGH Symposium: 12th Symposium, Keystone, June 2001 (2001) (0)
- hGH Symposium: 10th Symposium, Seville, April 1999 (1999) (0)
- Pulse Wave Velocity Is Associated With Cerebral White Matter Lesions in Type 2 Diabetes (2012) (0)
- OR09-3 THE PHARMACOKINETICS OF GHRELIN (2006) (0)
- Adipose Tissue LPL-activity does not Directly Determine Postabsorptive VLDL-TG Uptake in Obese Women (2006) (0)
- ' s response to reviews Title : Effects of human insulin and insulin aspart preparations on levels of IGF-I , IGFBPs and IGF bioactivity in patients with type 1 diabetes (0)
- OR1-1: GH treatment modulates mortality in adult onset GH deficiency and a discordant socio-economic status is apparent (2014) (0)
- hGH Symposium: Clinical Aspects of Growth Hormone Replacement Therapy Seville, Spain, April 1990: Proceedings (1990) (0)
- Effects of physiological bell-shaped elevations of free fatty acids on glucose metabolism and insulin sensitivity in humans (2007) (0)
- [Metformin-associated lactic acidosis]. (1990) (0)
- P-090. periovulatory gh levels are elevated due to increased gh production rate and burst frequency (1997) (0)
- The eighth hGH Symposium, Mannheim 1997, April 24-27, 1997 (1997) (0)
- Minutes of the 27th General Assembly of the European Association for the study of diabetes (2004) (0)
- hGH Symposium: 2nd Symposium, Amsterdam, June 1991 (1992) (0)
- Erratum (1986) (0)
- Short term elevation of estradiol concentrations does not affect hepatic VLDL-TG production (2009) (0)
- Chapter 16 – Effects of Growth Hormone Secretagogues on in vivo Substrate Metabolism in Humans (1999) (0)
- Effects of Growth Hormone on Muscle Mass and Function (1999) (0)
- hGH Symposium: 4th Symposium, Marrakech, May 1993 (1993) (0)
- Workshop C: novel topics in endocrinology. (2003) (0)
- A large dataset analysis of the long-term glucose counter-regulation to hypoglycemia in continuous glucose data to facilitate decision support in diabetes (2010) (0)
- Serum levels of the acid-labile subunit of the 150 KDA insulin-like growth factor binding protein complex: Impact of mode of growth hormone administration (1998) (0)
- [In Process Citation]. (2014) (0)
- Dose of growth hormone (GH) and not IGFI level at treatment start influences treatment outcome in GH deficient adults (GHDA): Data from the NordiNet International Outcome Study (IOS) (2010) (0)
- NO CHANGES IN INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 3 PROTEOLYSIS WITH SUBMAXIMAL EXERCISE (2003) (0)
- S.c. Injections of a Reversible Albumin-Binding GH Derivative (NNC0195-0092) in Adult Subjects with GH Deficiency is Well Tolerated (2014) (0)
- A Methodology for the Detection of Doping with Recombinant Human Growth Hormone. (2002) (0)
- Prevalence of elevated C-reactive protein among newly diagnosed type 2 diabetes patients in Denmark: Results from the population-based DD2 study (2013) (0)
- Agenda for the 32nd General Assembly of the European Association for the study of diabetes to be held in Vienna, in the Mozart Hall of the Austria Center Vienna, 4th September 1996 from 12.15–13.00 hours (1996) (0)
- Normal weight adult patients with Prader-Willi syndrome are not protected from insulin resistance during treatment with GH: results from a 12 month prospective study (2012) (0)
- glycerol levels in humans Effects of cortisol on lipolysis and regional interstitial (2016) (0)
- P-93 Visceral fat mass, not total fat mass or body mass index, is the strongest predictor of circulating ghrelin levels in humans (2008) (0)
- Reach further (2012) (0)
- Short title: Longacting insulins and the IGFsystem 3 (2014) (0)
- [Incidence of diagonal earlobe crease in ischemic heart disease]. (1975) (0)
- Insulin like growth factor I (IGF-1) administration induces fluid and sodium retention in healthy adults (1998) (0)
- GP3-1: Growth hormone (GH) replacement has a beneficial effect on glycosylated haemoglobin (HbA1c) levels in adult patients with GH deficiency (GHD) enrolled in the NordiNet® International Outcome Study (IOS) (2014) (0)
- The response of molecular isoforms of GH to acute exercise in trained adult males (2000) (0)
- hGH Symposium: 7th Symposium, Madrid, April 1996 (1996) (0)
- CARDIAC FUNCTION IN THE HORMONE DEFICIENT ADULTS GROWTH (2001) (0)
- Signs of accelerated carotid atherosclerosis assessed by MRI in newly diagnosed type 2 diabetes (2013) (0)
- Growth Hormone and Endocrinology: 14th Novo Nordisk Symposium and SGA Satellite Symposium, Estoril/Lisbon, March 2003: Proceedings (2003) (0)
- 24-hour ambulatory blood pressure and aortic dimensions in women with Turner syndrome (2007) (0)
- The Fourth hGH Symposium : Marrakech 1993, May 14 - 15, 1993 ; 17 tables (1993) (0)
- Growth Hormone and Endocrinology: 13th Novo Nordisk Symposium and SGA/IUGR Satellite Symposium, Budapest, April 2002: Proceedings (2003) (0)
- P-20 Growth hormone treatment in patients on hemodialysis is associated with an increase in serum mannose-binding lectin levels (2008) (0)
- hGH Symposium: 3rd Symposium, Sorrento, May 1992 (1992) (0)
- EFFECTS OF DIFFERENT GH DOSES ON THYROID METABOLISM, ENERGY EXPENDITURE AND BODY COMPOSITION IN THYROXINE SUBSTITUTED GH DEFICIENT PATIENTS (1993) (0)
- Growth hormone stimulates synthesis of mannan-binding lectin (2001) (0)
- The seventh hGH Symposium, Madrid, April 11-14, 1996 (1996) (0)
- Growth hormone - not only for growth, but for life? (2005) (0)
- Growth Hormone and Endocrinology: 15th Novo Nordisk Symposium and SGA Launch Symposium, Malta, April 2004: Proceedings (2004) (0)
- Subject Index Vol. 67, Suppl. 1, 2007 (2007) (0)
- [Diabetes and diet--does the rationale hold even in the 1990's?]. (1992) (0)
- [Tobacco smoking and diabetic microangiopathy]. (1979) (0)
- Six months physiological DHEA substitution in female adrenal failure: impact on quality of life and sexual parameters. (2007) (0)
- P-93 NordiNet®: FROM PATIENT MANAGEMENT TO OUTCOME RESEARCH TOOL (2006) (0)
- Effect of leptin on basal and follicle-stimulating hormone stimulated steroidogenesis in human granulosa cells (1999) (0)
- 9th novo nordisk hGH symposium, Lyons, France, 23-25 April, 1998 : proceedings (1998) (0)
- PEN4 EVALUATION OF THE ASSOCIATION BETWEEN THE QUALITY OF LIFE, SOCIAL CLASS AND HEIGHT IN THE GENERAL ADULT UK POPULATION (2006) (0)
- Adult Growth Hormone Deficiency — the Clinical Picture (1999) (0)
- [Heart function and heart disease in diabetes mellitus]. (1988) (0)
- Baseline characteristics and serum IGF1 levels in GH deficient (GHD) patients treated in the transition phase from adolescence into adulthood: data from the NordiNet International Outcome Study (IOS) (2010) (0)
- Increased gene expression of a truncated growth hormone (GH) receptor relative to the full-length receptor after 4 months of GH substitution in GH deficient adults (1998) (0)
- Switching to Biphasic Insulin Aspart 30 in Patients Uncontrolled on Human Premix Insulin (2010) (0)
- High prevalence of the metabolic syndrome among newly diagnosed type 2 diabetes patients in Denmark (2013) (0)
- Assessment of a continuous glucose monitoring calibration algorithm in hypoglycemia (2014) (0)
- Growth Hormone Effects on Day-to-Day Intermediary Metabolism (1992) (0)
- Growth Hormone Replacement and Cardiac Function in the Growth Hormone Deficient Adults (2001) (0)
- Increased arterial stiffness is independently associated with cerebral infarctions and white matter lesions in patients with type 2 diabetes despite good blood pressure and lipid control (2012) (0)
- Evidence for a specific heart disease in Type 1 (insulin-dependent) diabetic patients? (1987) (0)
- Two years of GH therapy improves body composition in adults with Prader-Willi Syndrome (2010) (0)
- Figure 1, Factors that stimulate and suppress GH secretion under physiological conditions (2015) (0)
- An alternative data mining oriented approach to the analysis of the long-term glucose counter-regulation to hypoglycemia in continuous glucose data (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jens Sandahl Christiansen?
Jens Sandahl Christiansen is affiliated with the following schools:
